Therapy designed for
real progress

PBM is noninvasive and painless, children generally find it comfortable, and no serious adverse events have been reported in the pediatric trials published so far. It is not entirely free of side effects. Some children in those trials experienced headaches or changes in sleep, and because the studies are short, we do not have long-term safety data. Eye protection is used throughout. Tell us before we begin if your child has a seizure disorder, is photosensitive, takes a photosensitizing medication, or has an implanted device, and check with your physician first. If headaches or sleep disruption appear during a course of treatment, tell us and we will stop.

Not for this specific use, and we would rather tell you than have you find out later. Our laser is FDA cleared, but that clearance covers uses such as temporary relief of pain and increased local blood circulation. Using it on the head for development is an off-label application. Off-label use is lawful and common throughout medicine; it means the FDA has not evaluated this particular use. We put this in writing before any family begins care.

Three studies have looked at it in children, and all three reported improvements. The strongest is a randomized trial where children receiving real treatment improved more on autism severity scores than children receiving a sham. That is a meaningful result and it is why we offer the therapy. It is also an early one: the three studies together cover fewer than eighty children, with short follow-up, and independent replication at a larger scale has not happened yet. Our Research page lists all three with their sizes and designs so you can judge for yourself. We offer PBM as an optional addition to therapy, not as a substitute for it.

A surgically implanted vagus nerve stimulator is FDA approved, for drug-resistant epilepsy and for treatment-resistant depression. That is a different thing from what we do. We use non-invasive stimulation at the ear, which involves no surgery, and no such device is FDA cleared for autism, anxiety, or developmental conditions in children. The pediatric research is at the pilot stage: small feasibility studies with encouraging early signals. We consider it investigational and we describe it that way.

Because promising tools are worth offering when two things are true. First, the core of our care is occupational therapy with well-established support: sensory integration, motor development, and reflex work. The newer tools sit on top of that foundation rather than replacing it. Second, families know what they are choosing before they decide and before they pay. If you would prefer an intensive without PBM or vagus nerve stimulation, just say so, and we will build the program without them.

At the evaluation we write specific, observable goals with you, using standardized assessments where appropriate. We re-measure against those goals rather than relying on impressions formed afterward. You receive the results whether they are favorable or not. If your child is not making progress we will say so, and we will discuss changing approach, referring you elsewhere, or stopping.